U.S. Food & Drug Administration: 10903 New Hampshire Avenue Silver Spring, MD 20993
U.S. Food & Drug Administration: 10903 New Hampshire Avenue Silver Spring, MD 20993
U.S. Food & Drug Administration: 10903 New Hampshire Avenue Silver Spring, MD 20993
Re: K202572
Trade/Device Name: GXR-Series Diagnostic X-Ray System
Regulation Number: 21 CFR 892.1680
Regulation Name: Stationary x-ray system
Regulatory Class: Class II
Product Code: KPR
Dated: August 27, 2020
Received: September 4, 2020
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced
above and have determined the device is substantially equivalent (for the indications for use stated in the
enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the
enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance
with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a
premarket approval application (PMA). You may, therefore, market the device, subject to the general
controls provisions of the Act. Although this letter refers to your product as a device, please be aware that
some cleared products may instead be combination products. The 510(k) Premarket Notification Database
located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination
product submissions. The general controls provisions of the Act include requirements for annual registration,
listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We
remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be
subject to additional controls. Existing major regulations affecting your device can be found in the Code of
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements
concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA
has made a determination that your device complies with other requirements of the Act or any Federal
statutes and regulations administered by other Federal agencies. You must comply with all the Act's
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see
https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-
combination-products); good manufacturing practice requirements as set forth in the quality systems (QS)
regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for
combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-
542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part
803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-
mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including
information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-
devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn
(https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See
the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE
by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For
Thalia T. Mills, Ph.D.
Director
Division of Radiological Health
OHT7: Office of In Vitro Diagnostics
and Radiological Health
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
510(k) Summary of Safety K202572
This 510(k) Summary of safety and effectiveness information is being submitted in accordance
with the requirements of SMDA 1990.
I. SUBMITTER
DRGEM Corporation
7F E-B/D Gwangmyeong Techno-Park 60, Haan-ro
Gwangmyeong-si, Gyeonggi-do, 14322 Korea
Email: radcheck@drgem.co.kr
II. DEVICE
Product Name: GXR-Series Diagnostic X-Ray System
Common Name: Digital Diagnostic X-ray System
Regulation Name: Stationary X-Ray System
Product Code: KPR
Regulation number: 892.1680
Regulatory Class: II
1
510(k) Summary of Safety
DRGEM) features accuracy, reproducibility and long-term stability with capacitor assisted
general line power supply. The APR (Anatomical Programming) and the optional AEC
(Automatic Exposure Control) features gives the user control of exposure factors,
automatically optimized for the radiological study selected.
The digital flat panel detectors provide spatial resolution, MTF, DQE and stability based on
fine pixel pitch. Selection of an anatomical study on the imaging software automatically sets
up the x-ray generator’s pre-programmed exposure technique setting and post image
processing for selected study. The subject device is able to use a total of 10 different digital
detectors, (8 new plus 2 cleared in the predicate, which have been previously cleared by the
510(k) process:
• VAREX, 4343R v3 - K172951(predicate)
• VAREX, 4336W v4- K161459 (predicate)
• VAREX, XRpad2 3025 HWC-M- K161942
• VAREX, XRpad2 4336 HWC-M- K161966
• VAREX, XRpad2 4343 HWC-M- K181526
• i-Ray, Mano4336W- K201004
• i-Ray, Mano4343W- K201043
• Vieworks, VIVIX-S1417N(NAW,NBW)-K163703
• Vieworks, VIVIX-S1717N(NAW,NBW)- K152894
• VAREX, 4343W- K161459
The GXR Series Diagnostic X-ray System consists of a combination of an x-ray generator,
and associated equipment such as tube stand, patient table, and, digital imaging system. The
main power cabinet contains the HT tank and control circuits, the filament drivers, the low
speed starter, and interface connections to the room equipment.
• Tube stand and patient table allows the operator to position the patient.
• Full Featured Imaging Software & Digital Image Processing
• Control console:
o The control console allows the operator to select the technique factors,
image receptors, etc., and to initiate an X-ray exposure.
o Real-time monitoring self-diagnosis function and Error code display
o Overload & HU protection and error message display
o Support programmable max. 1,280 APR conditions with APR utility software
o Automatic calibration without measurement equipment.
o Adaptable calibration keeps up accuracy through long-term usage
o Smaller, lighter and convenient modular design and user-friendly system
configuration
o Constant dose output due to kV and mA regulation during exposures.
o Large graphic LCD panel user-friendly controls for APR and technique
display at a glance,
o Time and mA / mAs selections are based on R’10 rule of ISO 497.
o Remote diagnosis software for system diagnosis via internet.
o Easy parameter setting and Firmware upgrade
o System diagnosis, Error log and Statistical data display
The image management software, RADMAX Digital Imaging Software (K182537) by
DRGEM, is used in both the predicate and subject device to serve as a convenient
interface to the hardware and images. Anatomical view-based digital image processing
automatically optimizes and enhances the quality of the captured images. RADMAX
2
510(k) Summary of Safety
(K182537) Digital Imaging Software is designed for acquiring images and processing the
acquired images. The software can be used together with a digital X-ray detector and or
an X-Ray generator. The main features of the RADMAX software are controlling and
interfacing the detector, acquiring images after X-ray, storing acquired images, managing
data, and image processing. It can also perform system control such as the collimation
size, and filter selection. The following are general features.
• Windows based graphic user interface
• Multi-image display (1x1 ~ 4x4)
• Multi-image selection
• Auto display layout changing function
• X-ray generator control panel
• Unlimited procedure step
• Quick step-add feature and image maintenance feature by popup menu
• ROI changing and creation feature
• Marker feature (support the creation of unlimited number of markers by user)
• Multi-language support
• EXCEL sheet for language support (only possible on Microsoft Office automation
environment)
• DAP meter (optional)
• Unlimited PACS code (CPT code)
• Default anatomic program more than 700
• Support DICOM Worklist SCU, DICOM Storage SCU and transfer function
• Support DICOM Multi-transfer function
• High-performance post-processing feature
• Copy & Move Images
• Dose monitoring function
• Built-in memory function
• Grid line suppression function
• Reject analysis function
3
510(k) Summary of Safety
High Frequency X-
ray Generator
220~230VAC 220~230VAC
Line voltage None
380/400/480VAC 380/400/480VAC
4
510(k) Summary of Safety
5
510(k) Summary of Safety
FDA
Std # Safety/EMC Standards Description Consensus
Standard #
IEC 60601-2-28
IEC 60601-2-28 Medical electrical equipment Part 2: Particular requirements for the
12-204
safety of X-ray source assemblies and X-ray tube assemblies for
medical diagnosis.
Conclusion:
The 510(k) Pre-Market Notification for the GXR-Series Diagnostic X-Ray System, contains adequate
information, data, and nonclinical test results to enable FDA - CDRH to determine substantial
equivalence to the predicate device. The subject device will be manufactured in accordance with the
voluntary standards listed in the voluntary standard survey. The new device and predicate devices
are substantially equivalent in the areas of technical characteristics, general function, application,
and intended use does not raise any new potential safety risks and is equivalent in performance to
existing legally marketed devices.
Nonclinical tests demonstrate that the device is as safe, as effective, and performs comparably to
the predicate device.